News

Boehringer Ingelheim inaugurated its state-of-the-art Biologicals Development Center (BDC) in Biberach an der Riß, Germany. The new high-tech facility underlines the company’s strong…
Read More...

ALX Oncology Holdings Inc. announced it has entered into a clinical trial collaboration and supply agreement with Sanofi to evaluate the combination of evorpacept, a next generation…
Read More...

Lantheus Holdings, Inc. and POINT Biopharma Global, Inc. announced the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for 177Lu-PNT2002 for the treatment of…
Read More...

Oncotelic Therapeutics, Inc. announced a strategic partnership with Vectara, a company specializing in innovative Natural Language Understanding (NLU) technologies, to accelerate the…
Read More...

Genentech, a member of the Roche Group announced that the U.S. Food and Drug Administration (FDA) has approved Polivy (polatuzumab vedotin-piiq) in combination with Rituxan (rituximab),…
Read More...

ANGLE plc is delighted to announce it has signed an agreement with BioView Ltd. ("BioView") (BIOV.TA) to develop a liquid biopsy circulating tumor cell (CTC) HER2 assay for breast…
Read More...

AbbVie (NYSE: ABBV) today announced the European Commission (EC) approved RINVOQ (upadacitinib, 45 mg and 15 mg and 30 mg ) as the first oral Janus Kinase (JAK) inhibitor for the…
Read More...

Bio-Techne, a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities, and Lunaphore, a Swiss life sciences…
Read More...

Merck, known as MSD outside the United States and Canada, and Prometheus Biosciences, Inc. announced that the companies have entered into a definitive agreement under which Merck,…
Read More...

Biogen Inc. and Denali Therapeutics Inc. announced that Biogen has exercised the option to license Denali’s Antibody Transport Vehicle (ATV): Amyloid beta program (ATV:Aβ). Accumulation…
Read More...

IPS HEART has been granted rare pediatric drug designation by the FDA for GIVI-MPC, a first-in-class stem cell therapeutic to create new skeletal muscle with 100% full length dystrophin…
Read More...

Twist Bioscience Corporation announced the launch of Twist T-cell Receptor (TCR), and Twist chimeric antigen receptor (CAR) Libraries. These new libraries provide researchers with the…
Read More...

Tiziana Life Sciences Ltd. announced it plans to investigate intranasal foralumab for the treatment of Long COVID. The work is supported by foralumab’s well-established role in…
Read More...

ImaginAb Inc., a global biotechnology company developing 89Zr crefmirlimab berdoxam (CD8 ImmunoPETTM) imaging agent and radiopharmaceutical therapies (RPT), is pleased to announce the…
Read More...

PharmaLex Group, the leading provider of specialized services for the pharma, biotech and medtech industries worldwide, has announced its intention to merge with Cpharm, the leading…
Read More...

Cognizant announced it is working with Boehringer Ingelheim, a leading research-driven biopharmaceutical company, to advance the speed and quality of medicinal therapy development.…
Read More...

Fusion Pharmaceuticals Inc., a clinical-stage oncology company focused on developing next-generation radiopharmaceuticals as precision medicines, announced the clearance of…
Read More...

Panbela Therapeutics, Inc. announced that it has regained the North American rights to develop and commercialize Flynpovi (the combination of CPP-1X (eflornithine) and sulindac) in…
Read More...

Insilico Medicine (“Insilico”), a clinical-stage generative artificial intelligence (AI)-driven drug discovery company, announced that it has successfully discovered a potent,…
Read More...

Centogene N.V. announced it has extended its partnership with Takeda to diagnose patients with Lysosomal Storage Disorders (LSDs). Under the renewed one-year partnership agreement,…
Read More...